Nair A, Bolaji O, Zonshayn D, Desai D, Cheriyath P, Okere A. Racial, ethnic, and gender disparities among patients with acute coronary syndrome in the setting of COVID-19: a nationwide analysis.

Study Objectives: The clinical manifestations of acute coronary syndromes (ACSs) vary, and patients present frequently with symptoms other than chest pain. In this analysis, a large contemporary ...

2009;7(5):521-532. There is still considerable debate concerning the protective effect of β-blocker therapy towards perioperative coronary events, and several randomized, controlled trials have ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

A biodegradable polymer sirolimus-eluting stent (BP-SES) was noninferior to currently-used second-generation drug-eluting stents (DES) in terms of target lesion failure (TLF) at one year in patients ...

Acute coronary syndromes are sudden episodes of reduced or no blood flow and therefore oxygen delivery to part of the heart, usually as a result of narrowing or blockage of an artery.

Patients were identified as having CAD if they had a history of acute coronary syndrome, coronary artery angioplasty ... Follow-up data regarding β-blocker therapy included the initiation date and, if ...

Gao X, Kan J, Wu Z, et al. IVUS-Guided vs Angiography-Guided PCI in Patients With Diabetes With Acute Coronary Syndromes: The IVUS-ACS Trial. JACC Cardiovasc Interv 2024;Oct 27:[Epublished]. Editorial ...

ACE indicates angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker; CABG, coronary artery bypass graft; LVEF, left ventricular ejection fraction; NSTE‐ACS, non–ST‐segment–elevation ...

This recommendation seems particularly prudent in the era of aggressive revascularization for acute coronary syndrome, when more contemporary studies have demonstrated no mortality benefit from the ...

Conclusions—Aspirin has been shown to be beneficial after a myocardial infarction and for other acute coronary syndromes. However, variances in the proportion of patients with suspected ischaemic ...